Cumberland Q2 Adj $0.01 Down From $0.16 YoY, Sales $9.85M Down From $10.89M YoY
Portfolio Pulse from Benzinga Newsdesk
Cumberland Pharmaceuticals (NASDAQ:CPIX) reported a significant decrease in Q2 earnings and sales compared to the same period last year. Earnings per share dropped by 93.75% to $0.01, and sales fell by 9.55% to $9.85 million.
August 06, 2024 | 9:41 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cumberland Pharmaceuticals reported a sharp decline in Q2 earnings and sales. EPS fell by 93.75% to $0.01, and sales decreased by 9.55% to $9.85 million.
The significant drop in both earnings per share and sales is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100